Oligodendrocyte breakdown: a driving force in Alzheimer’s?
The advantage of blood-based screening for Alzheimer’s disease
Glial activation and Alzheimer’s disease
Prevention is better than cure: identifying the people who are at risk of Alzheimer’s disease
Finding novel treatments rapidly: the ARUK Drug Discovery Alliance